Latest Updates
-
Uranus In Gemini Transit Returns For The First Time Since The 1940s, Starts A 7-Year Shift Across Zodiac Signs -
Sita Navami 2026: Puja Muhurat, Vrat Vidhi And Spiritual Benefits For Stronger Relationships -
World Malaria Day 2026: Date, History, Significance, and Why It Matters -
Bakery Style Soft Texture Banana Cake Recipe -
Horoscope for Today April 25, 2026 - Steady Steps, Clear Focus, Practical Gains -
Rich Mughlai Special Chicken Korma Recipe -
A Hidden Foodborne Infection: What You Should Know About Cyclospora -
Melt-in-Mouth Sweet Mysore Pak Recipe: A Classic Indian Delight -
Between Meetings and Meals: Why American Pecans Are the Ideal Midday Snack -
Skincare Hacks 101: 7 Summer Hacks That Actually Work in 40°C Heat
Tata Medical Says Omisure RT-PCR Test Upgraded To Detect BA.2 Sub-lineages Of Omicron

Tata Medical and Diagnostics on February 8 said its OmiSure RT-PCR test has been upgraded to detect the new BA.2 sub-lineages of Omicron. In an evaluation carried out by ICMR and the Virus Research & Diagnostics Laboratory, Kasturba Hospital for Infectious Diseases, Mumbai, the upgraded OmiSure successfully detected BA.1, BA.1.1, and BA.2 sub-lineages of Omicron, the company said in a statement. With this, the OmiSure RT-PCR test kit is now capable of detecting all the sub-lineages of Omicron prolific in India at present, it added.
"We are glad to announce that OmiSure detects all omicron sub-lineages, including newer BA.1, BA.2 accurately and confirmed by ICMR. It is a testament to our strength that we upgraded the OmiSure within a week and OmiSure is the most economical variant testing platform to address the market needs," TATA Medical and Diagnostics CEO and Managing Director Girish Krishnamurthy noted.
OmiSure RT-PCR test decreases the load on sequencing; allows healthcare authorities to assess the evolution of variants and take timely action to control spread.
Additionally, samples negative for Omicron on the OmiSure test can be prioritised for sequencing as the chances of detecting other variants and newer mutations are higher in these samples, the company stated.
Omicron illustration by FreePik
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications